Neurometrix, inc. (NURO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-657

-

-

-

2,050

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from operating activities:
Net Income (Loss) Attributable to Parent

-

-

-

-

-

-

1,086

573

1,166

-

-3,508

-3,237

-3,232

-2,814

-3,908

-4,095

-4,095

-2,709

-3,203

-1,203

-2,071

-2,909

-1,461

-2,170

-1,224

-3,703

-716

-1,345

-2,253

-1,872

-2,610

-2,772

-2,752

-2,416

-2,430

-2,436

-2,697

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41

36

31

34

34

37

38

41

41

119

65

70

77

90

94

114

Depreciation

23

-

-9

75

31

-

25

85

55

-

72

64

61

-

64

62

61

-

65

66

29

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

144

5

120

19

44

31

42

30

341

39

56

47

66

48

54

55

66

56

74

88

83

81

71

60

76

86

62

32

63

75

86

78

79

365

133

192

145

CompensationObligationSettlement

43

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

IdleFacilityImpairmentCharge

87

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory Write-down

0

0

0

1,895

700

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

56

17

51

25

0

-24

64

194

20

32

4

41

Fair Value Adjustment of Warrants

-

-

-

-

-

-

-

-

-

0

-0

-130

-77

-47

-56

-77

-94

-609

-151

-2,135

-1,186

504

-564

-475

-514

2,327

-881

-1,155

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

87

-175

-202

-245

-110

-532

501

-474

-814

625

-561

34

211

167

177

-162

-251

-96

313

-332

341

-31

78

2

139

-228

57

29

-33

-44

92

-351

-39

-83

-63

-196

-338

Inventories

-10

540

-849

1,025

182

264

173

565

-283

-416

308

280

-55

90

114

-465

424

16

-149

586

-44

49

26

-61

102

75

-192

11

-14

46

-313

-74

-353

-218

295

-264

-363

Increase (Decrease) In Collaboration Receivable

-7

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current and long-term assets

-312

-54

-428

138

101

66

184

-266

-343

519

312

290

-236

346

209

341

-142

-36

318

510

-344

168

91

-4

-60

-80

184

-100

-56

-69

177

26

-57

-94

172

-169

-18

Accounts payable

-102

87

-372

452

-740

154

351

436

-369

13

-46

354

-329

19

69

-736

379

55

161

-49

311

0

-11

76

135

59

54

-17

-31

-148

-59

65

-229

168

286

-55

-28

Accrued expenses

-458

-273

-300

-240

657

-262

-52

-92

-0

212

311

245

121

-287

398

-81

317

26

25

-192

197

157

204

564

72

-263

-174

117

265

-358

201

-32

-340

-62

491

-148

-39

Increase (Decrease) in Accrued Product Returns

-86

25

-78

14

-374

-4

-206

-92

-553

211

40

90

-161

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (Decrease) in Contract with Customer, Liability

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (Decrease) in Deferred Collaboration Income

0

-

-

-

-1,774

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

266

-85

116

-1

217

408

-223

-475

80

643

-56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, deferred costs, and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-95

89

-56

-

-72

-82

-109

Net Cash Provided by (Used in) Operating Activities

-763

-61

-1,737

-2,242

420

-721

387

1,116

2,079

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,861

-1,801

-

-2,338

-2,041

-2,585

-1,442

-1,873

-1,609

-1,852

Deferred revenue, deferred costs, and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

-

-17

-18

-16

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-3,257

-3,353

-3,623

-3,661

-4,177

-3,617

-3,479

-3,430

-3,546

-2,643

-2,323

-1,910

-1,836

-1,608

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from investing activities:
Purchases of fixed assets

-

-

-

-

-

37

-24

104

25

92

32

37

0

12

32

27

28

0

91

327

175

155

54

13

4

58

11

9

6

23

55

4

24

-5

30

59

25

Repurchase of preferred stock and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3,206

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Provided by (Used in) Investing Activities

-

-

-

-

-

-37

24

-104

-25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9

-6

-

-55

225

-24

5

-30

118

-25

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-37

0

-12

-32

-27

-28

0

-91

-327

-175

-155

-54

-13

-4

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities:
Net proceeds from issuance of stock and warrants

453

7

0

7

0

-

-

-

-

-

3,257

10

6,302

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from issuance of stock and other equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-65

7,537

-

-

-

-

Payments on capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

7

5

5

5

5

5

4

4

3

4

6

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

10

6,302

16

-68

6,795

-76

6,825

0

10,109

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Cash Provided by (Used in) Financing Activities

453

7

0

7

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,571

-5

-

-5

-71

7,532

13

-3

10

-6

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect

-309

-60

-1,771

-2,242

420

-750

421

1,011

2,054

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from issuance of stock and warrants, including private offerings and equity plans

-

-

-

-

-

-

-

-

-

-

-

-

-

16

-68

6,795

-76

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

357

-3,285

2,948

-3,619

-3,762

2,591

-3,723

3,346

-3,522

6,235

-2,818

-2,465

-2,006

6,110

-1,612

1,359

-1,750

2,700

-1,813

-2,226

-2,399

-1,887

4,922

-1,424

-1,907

-1,479

-1,884

Supplemental disclosure of cash flow information:
Stock Issuance Settle Incentive Compensation Obligation

43

0

0

0

0

-

-

-

-

-

-

-

-

0

0

0

318

-563

563

0

-281

0

0

0

-104

0

0

0

-285

0

0

0

0

-

-

-

-

Capital Expenditures Incurred but Not yet Paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

82

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued in exchange for warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

127

-

-

-

-